WELL Health Technologies (TSE:WELL) Given New C$7.00 Price Target at Scotiabank

WELL Health Technologies (TSE:WELL) had its target price hoisted by research analysts at Scotiabank from C$6.00 to C$7.00 in a research report issued to clients and investors on Monday,BayStreet.CA reports.

A number of other brokerages have also recently commented on WELL. Ventum Financial decreased their target price on WELL Health Technologies from C$8.00 to C$7.00 and set a “buy” rating on the stock in a report on Tuesday, October 29th. CIBC boosted their price objective on WELL Health Technologies from C$5.25 to C$7.00 in a research note on Friday. Finally, Haywood Securities lifted their price target on shares of WELL Health Technologies from C$8.00 to C$10.00 in a report on Friday.

WELL Health Technologies Stock Performance

Shares of WELL traded up C$0.21 during trading hours on Monday, hitting C$7.00. The stock had a trading volume of 1,237,805 shares, compared to its average volume of 885,376. The stock has a fifty day moving average price of C$5.14 and a 200 day moving average price of C$4.69. The firm has a market capitalization of C$1.74 billion, a PE ratio of 12.33, a PEG ratio of -1.93 and a beta of 1.20. WELL Health Technologies has a 12 month low of C$3.41 and a 12 month high of C$7.05. The company has a debt-to-equity ratio of 41.57, a current ratio of 1.25 and a quick ratio of 1.02.

About WELL Health Technologies

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.